IOmx Therapeutics

OverviewSuggest Edit

iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By systematically screening human tumor cells, the Company has already identified a number of novel targets and analyzed their mode of action. The Company was founded on the successful concept of cancer immune-checkpoint therapy, which works by breaking down the inherent resistance mechanisms of tumors against immune attack. Immune resistance of tumors is often mediated by cell surface molecules that stimulate immune-inhibitory receptors on T cells. Reactivating the host immune response by neutralizing these negative interactions is the idea behind cancer immune-checkpoint therapy.
TypePrivate
Founded2016
HQPlanegg, DE
Websiteiomx.com

Locations

IOmx Therapeutics is headquartered in
Planegg, Germany

Location Map

Latest Updates

Employees (est.) (Sept 2021)27
Cybersecurity ratingCMore

Key People/Management at IOmx Therapeutics

Gerald H. Moeller

Gerald H. Moeller

Chairman of the Supervisory Board
Henrijette Richter

Henrijette Richter

Vice-Chairwoman
Nisit Khandelwal

Nisit Khandelwal

Co-Founder and Managing Director
Apollon Papadimitriou

Apollon Papadimitriou

CEO
Marcus Irsfeld

Marcus Irsfeld

CFO
Show more

IOmx Therapeutics Office Locations

IOmx Therapeutics has an office in Planegg
Planegg, DE (HQ)
13 Fraunhoferstraße
Show all (1)

IOmx Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

IOmx Therapeutics total Funding

$44.7 m

IOmx Therapeutics latest funding size

$44.69 m

Time since last funding

5 years ago

IOmx Therapeutics investors

IOmx Therapeutics's latest funding round in September 2016 was reported to be $44.7 m. In total, IOmx Therapeutics has raised $44.7 m
Show all financial metrics

IOmx Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

IOmx Therapeutics Online and Social Media Presence

Embed Graph

IOmx Therapeutics Frequently Asked Questions

  • When was IOmx Therapeutics founded?

    IOmx Therapeutics was founded in 2016.

  • Who are IOmx Therapeutics key executives?

    IOmx Therapeutics's key executives are Gerald H. Moeller, Henrijette Richter and Nisit Khandelwal.

  • How many employees does IOmx Therapeutics have?

    IOmx Therapeutics has 27 employees.

  • Who are IOmx Therapeutics competitors?

    Competitors of IOmx Therapeutics include Strides Pharma, LFB and Cadila Pharmaceuticals.

  • Where is IOmx Therapeutics headquarters?

    IOmx Therapeutics headquarters is located at 13 Fraunhoferstraße, Planegg.

  • Where are IOmx Therapeutics offices?

    IOmx Therapeutics has an office in Planegg.

  • How many offices does IOmx Therapeutics have?

    IOmx Therapeutics has 1 office.